Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Walker

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastomaRoger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Immunomodulatory spherical nucleic acidsAleksandar F Radovic-Moreno, Natalia Chernyak, Christopher C Mader, et al.
British Journal of Neurosurgery|February 14, 2018
Development of a pre-operative scoring system for predicting risk of post-operative paediatric cerebellar mutism syndromeJo-Fen Liu, Robert A Dineen, Shivaram Avula, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final reportAstrid K Gnekow, David A Walker, Daniela Kandels, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2017
Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]Astrid K Gnekow, David A Walker, Daniela Kandels, et al.
Pediatric Blood & Cancer|August 15, 2015
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, et al.
The Journal of Clinical Investigation|October 19, 2013
Tracking the clonal origin of lethal prostate cancerMichael C Haffner, Timothy Mosbruger, David M Esopi, et al.
The Lancet. Oncology|July 24, 2007
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective studyRichard G Grundy, Sophie A Wilne, Claire L Weston, et al.
Cancers|February 11, 2023
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical TrialsRuman Rahman, Miroslaw Janowski, Clare L Killick-Cole, et al.
Ecancermedicalscience|April 26, 2016
Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain TumoursAudrey Nailor, David A Walker, Thomas S Jacques, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastomaRoger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Immunomodulatory spherical nucleic acidsAleksandar F Radovic-Moreno, Natalia Chernyak, Christopher C Mader, et al.
British Journal of Neurosurgery|February 14, 2018
Development of a pre-operative scoring system for predicting risk of post-operative paediatric cerebellar mutism syndromeJo-Fen Liu, Robert A Dineen, Shivaram Avula, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final reportAstrid K Gnekow, David A Walker, Daniela Kandels, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2017
Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225]Astrid K Gnekow, David A Walker, Daniela Kandels, et al.
Pediatric Blood & Cancer|August 15, 2015
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, et al.
The Journal of Clinical Investigation|October 19, 2013
Tracking the clonal origin of lethal prostate cancerMichael C Haffner, Timothy Mosbruger, David M Esopi, et al.
The Lancet. Oncology|July 24, 2007
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective studyRichard G Grundy, Sophie A Wilne, Claire L Weston, et al.
Cancers|February 11, 2023
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical TrialsRuman Rahman, Miroslaw Janowski, Clare L Killick-Cole, et al.
Ecancermedicalscience|April 26, 2016
Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain TumoursAudrey Nailor, David A Walker, Thomas S Jacques, et al.
Pageof 8